Christopher Leidli Email and Phone Number
Christopher Leidli work email
- Valid
- Valid
- Valid
- Valid
Christopher Leidli personal email
Christopher Leidli phone numbers
The Genoplex mission is to build the first AI-enabled health tech solution to help patients gain rapid access to advanced therapies to improve outcomes and health equity. Advanced therapies include cell therapies, gene therapies, bispecific antibodies, antibody-drug conjugates, and radiopharmaceutical therapies.What We DoWe are the first health technology company to develop an AI-powered copilot that is exclusively focused on improving patient access to advanced therapies.Our digital platform, Advanced Therapy Connect™, is an AI-powered matching engine that accelerates patient referral and treatment so that patients can benefit from these potentially curative therapies. As the Founder and CEO of Genoplex, I am driven by the belief that we can make a significant difference in patients' lives by helping to improve access to these innovative therapies. I believe in a future where patients can harness the power of their own immune cells to fight cancer and other diseases. My goal is to contribute to the advancement of precision medicines and advanced regenerative therapies, creating a future where patients have more control over their healing journeys.Send a DM to discuss partnership, investment and business opportunities.
Genoplex.Ai
View-
Founder And CeoGenoplex.Ai Sep 2023 - PresentWilmington, De, UsWe are building software and data solutions to help accelerate patient access to advanced medicines, including cell therapies, gene therapies, biologics, and radiopharmaceuticals.
-
Founder And Managing PartnerBoulder Biotech Launch Specialists, Llc Sep 2019 - PresentI help Life Science companies prepare for launch and commercialization with a focus on advanced therapies, including Precision Medicines, Biologics, Antibody Drug Conjugates (ADCs) and Cell and Gene Therapies. -
Senior Vice President, Advanced Medicines SolutionsVerascity Science Jan 2024 - Nov 2024Responsible for crafting and executing the advanced medicines vision and growth stratey for Verascity Science, a leading medical communications agency. I support medical communications, marketing, digital, social media, market access, and commercialization strategy across all Brightly Network agencies (BluPrint Oncology, Blendworks). In this role, I help biopharma companies develop and commercialize advanced therapies, including Precision Medicines, Biologics, Immunotherapies, Antibody Drug Conjugates (ADCs) and Cell and Gene Therapies. Drive omnichannel and digital marketing and provide generative AI subject matter expertise to support client solutions and also lead content development for scientific, medical and promotional communications, including social media, working closely with partner agency - BluPrint Oncology. -
Senior Director, Cell Therapy MarketingIovance Biotherapeutics, Inc. Jun 2020 - Jun 2022San Carlos, California, UsAt Iovance, I led the commercial launch readiness for the first T cell therapy to treat solid tumors. Developed the marketing plan working across clinical development, manufacturing, and commercial functions to potentially lead to the first Tumor Infiltrating Lymphocyte (TIL) FDA filing in history. Served as the primary point of contact for developing and executing treatment center onboarding, training, and dry runs. Spearheaded initiatives to advance start-up operational capabilities within the company; created the digital ecosystem and all necessary CRM and LMS systems and processes required to enable successful launch. Cultivated the organization’s start-up culture and overall company vision; role modeled leadership and nurtured environment that promotes high performance. -
Director, Brand Promotions LeadArray Biopharma Inc. Feb 2016 - Jun 2019Boulder, Co, UsAt Array BioPharma, I was responsible for all aspects of U.S. Commercial Launch, HCP and Payer Marketing of BRAFTOVI (encorafenib) + MEKTOVI (binimetinib) targeted therapy combination for patients with BRAF-mutant metastatic melanoma. Achieved over $135M in U.S. net sales within first 12 months of launch; demand significantly exceeded forecasts. Advanced "start-up" operational capabilities by working with IT to create the multichannel digital ecosystem and all necessary CRM and LMS systems and processes required to enable successful commercialization. -
Global Commercial LeaderBayer Healthcare May 2012 - Jan 2016Leverkusen, North Rhine-Westphalia, DeI led the WW launch of STIVARGA [regorafenib], a molecular targeted therapy, that was behind-schedule and successfully aligned the global cross-functional team on commercialization strategy; delivered $250M in sales within first year of approval. -
Senior Director, Key Customer MarketingSanofi Dec 2008 - May 2012Paris, France, FrDeployed successful marketing campaigns and owned their implementation from ideation to execution. Built strategic relationships and partnered with key industry players, agencies, and vendors.Developed and negotiated novel contracting strategies for multibillion dollar Oncology portfolio in highly competitive, Medicare Part B buy-and-bill market.Built, staffed, and led National Accounts and Payer Marketing team with responsibility for developing and executing Payer and healthcare segment strategies and tactics across Oncology portfolio.Increased TAXOTERE (docetoxel) and ELOXATIN (oxoliplotin) sales significantly at target national accounts by providing appropriate value messages and contracting tools to Account Team.Produced valuable and engaging content that attracted and converted target groups; oversaw and approved marketing material. Measured and reported on the performance of marketing campaigns; gained insight and assessed against goals. -
District Sales ManagerSanofi Jan 2006 - Nov 2008Paris, France, Fr
-
Director, U.S. Oncology MarketingSanofi May 2004 - Jan 2006Paris, France, Fr
-
Director, Global Oncology MarketingJohnson & Johnson Jun 2002 - Apr 2004New Brunswick, Nj, UsCrafted Oncology Therapeutic Area Strategy and provided commercial input for hematology and solid tumor portfolio resulting in the funding and advancement of two new pipeline programs.Evaluated the commercial potential of 5 novel pipeline assets, in the oncology space, using market analysis and financial modeling, to support in-licensing and business development, resulting in the in-licensing of two new assets. -
Oncology Product ManagerHuman Genome Sciences, Inc. 2000 - 2002Rockville, Md, UsDeveloped clinical development and commercial plans for genomics-derived products targeting lymphoma and other B-cell malignancies.Led a cross-functional team of medical experts and genome data scientists to develop valuation models using NPV to analyze commercial potential of pipeline products. -
Immuno-Oncology Research AssistantAmgen, Inc. Sep 1992 - Oct 2000Thousand Oaks, Ca, UsLed immunology and cancer biology research team in genomic and proteomic analysis to identify targets for therapeutic intervention with biologics, including engineered proteins and neutralizing antibodies. Worked with process development to support scale up and analytical validation utilizing multiplexed cell-based assays and flow cytometry to characterize end products.
Christopher Leidli Skills
Christopher Leidli Education Details
-
Usc Marshall School Of BusinessHealth Care Policy -
University Of Cincinnati College Of MedicineMolecular Physiology And Pharmacology
-
University Of CincinnatiBiopsychology
-
Gilmour AcademyCollege/University Preparatory And Advanced High School/Secondary Diploma Program
Frequently Asked Questions about Christopher Leidli
What company does Christopher Leidli work for?
Christopher Leidli works for Genoplex.ai
What is Christopher Leidli's role at the current company?
Christopher Leidli's current role is CEO & Founder @ Genoplex.ai | Leveraging AI technology to accelerate patient access to advanced therapies.
What is Christopher Leidli's email address?
Christopher Leidli's email address is ch****@****dli.com
What is Christopher Leidli's direct phone number?
Christopher Leidli's direct phone number is +130338*****
What schools did Christopher Leidli attend?
Christopher Leidli attended Usc Marshall School Of Business, University Of Cincinnati College Of Medicine, University Of Cincinnati, Gilmour Academy.
What skills is Christopher Leidli known for?
Christopher Leidli has skills like Oncology, Marketing Strategy, Business Development, Marketing, Hospital Sales, Clinical Development, Market Access, Global Marketing, Strategy, Cross Functional Team Leadership, Biopharmaceuticals, Competitive Analysis.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial